Quality measure concepts
As a publisher of clinical practice guidelines and other guidance, IDSA has taken a leadership role in generating concepts for quality improvement measures specific to the best practices associated with the treatment of infectious diseases. These measure concepts are designed to support ID physicians, pharmacists and clinicians in local quality improvement activities. Each includes suggested specifications for collection and supporting references where applicable. These measure concepts can be used to assess performance on a key element of a guideline or best practice, identify potential opportunities for improvement or monitor progress of an improvement project.
IDSA welcomes feedback from members on measure concepts, including suggestions for specifications and learning from testing their use. Please contact us with input or questions.
Staphylococcus aureus Measure Set (updated January 2025)
Treatment of Clostridioides difficile Infection (CDI) (updated June 2025)
Endorsed Measures Related to Infectious Disease and Antimicrobial Stewardship
The Centers for Medicare & Medicaid Services uses quality measures for its public reporting and value-based purchasing programs and prioritizes measures endorsed by consensus-based entities. Information on the endorsement process is available here.
IDSA’s Quality Measurement & Improvement Subcommittee reviews measures endorsed by the Partnership for Quality Measurement and identifies those related to infectious disease and antimicrobial stewardship.
Antibiotic Selection and Duration with Uncomplicated Community-Acquired Pneumonia
Two measures developed by the University of Utah were endorsed by the Partnership for Quality Measurement in 2024 and should be considered by Antimicrobial Stewardship Programs: